News About: Pharm. Industry
Sales of foreign drug companies on rapid growth.
A serial event of the M&A among the multinational drug corporations drew a rapidly changed picture in the world pharmaceutical industry. It is not exceptional for such a world trend directly to reflect to their affili...
Cisapride market to be more competitive by Hanmi's new entry.
Hanmi introduced Cisaple tablet (Cisapride 5mg), a GI motility regulator to compete with Janssen's Prepulcid and other's Cisapride generic markets.
Cisapride generics were introduced recently by Daewoong and Kyung...
Il Dong headach on the similar company name
A dietary supplemental product named "Long-gard", promoting for a children's growth, was sold in the pharmacy market under the company named "Il Dong Natural", for which Il Dong pharmaceutical company worried their bu...
Drug fair trade policy conflicted with hospital's demands for supply margins.
Even after implementation of the government new insurance drug pricing policy, the Actual Purchasing Price Reimbursement System, many hospitals have asked for 5 to 10% of drug supply margins, for which the drug indust...
Cisapride on harsh patent dispute.
Janssen Korea's Prepulcid (cisapride), one of the top ethical drugs in the hospital market and a GI motility regulator, had earlier met an unprecedented challenge with many Cisapride generic products developed by dome...
Total value bidding system needed to reform.
National and public general hospitals have exercised so called "Total value bidding system" when inviting their public tender for purchasing of insurance drugs, which was packaged by a therapeutic group or by a total ...
Bona-S requests for proforma invoice of insurance drugs in trouble.
The actual purchasing price reimbursement system faced many difficulties from the public tenders invited by the national and public medical institutes for their purchase of insurance drugs at extremely lower prices. U...
Compensation for damage on dispute between Korean and Japanese companies.
Il Dong recently filed an arbitration to the Japanese International Commerce Arbitration Association (File No. 99-11) against Mitsubishi Tokyo Pharmaceutical Co. for settlement of the dispute on Arlnert.
Il Dong ma...
Local franchise drug companies actively to tie up with foreign drug firms.
To prepare forthcoming new market environmental changes possibly caused by the implementation of medical and pharmacy separation system as scheduled from July 1, many local hospital sales oriented drug companies and f...
Daewoong and Samyangsa on strategic tie-up.
Daewoong and Samyangsa made a strategic business tie-up on Jan. 21 for the production and the marketing of the patch type of drugs, aiming at a synergic effect by both parties who may intensify and exchange their powe...
